8月10日，毛戈平盘中上涨5.08%，报56.85港元，成交额1.27亿港元。
消息面上，美妆板块今日集体走强，同板块上美股份涨6.49%、巨子生物涨4.36%，行业联动效应显著。此前美银证券重申毛戈平"买入"评级，目标价95港元，预计公司上半年收入增长超20%，线上渠道占比提升带动毛利率扩张，净利润增速有望超30%。管理层此前表示下半年收入增长将加快，全年目标为30%增长。申万宏源亦指出公司底妆品类持续强势，618期间多款产品畅销，二季度业绩有望高增长。随着半年报窗口临近，市场对业绩兑现的乐观预期推动资金流入。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.